JPWO2021046207A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021046207A5
JPWO2021046207A5 JP2022513855A JP2022513855A JPWO2021046207A5 JP WO2021046207 A5 JPWO2021046207 A5 JP WO2021046207A5 JP 2022513855 A JP2022513855 A JP 2022513855A JP 2022513855 A JP2022513855 A JP 2022513855A JP WO2021046207 A5 JPWO2021046207 A5 JP WO2021046207A5
Authority
JP
Japan
Prior art keywords
polypeptide
nanostructure
protein
amino acid
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022513855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546813A (ja
JP2022546813A5 (https=
JP7818504B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049183 external-priority patent/WO2021046207A1/en
Publication of JP2022546813A publication Critical patent/JP2022546813A/ja
Publication of JPWO2021046207A5 publication Critical patent/JPWO2021046207A5/ja
Publication of JP2022546813A5 publication Critical patent/JP2022546813A5/ja
Priority to JP2025142204A priority Critical patent/JP2025172875A/ja
Application granted granted Critical
Publication of JP7818504B2 publication Critical patent/JP7818504B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513855A 2019-09-04 2020-09-03 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用 Active JP7818504B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025142204A JP2025172875A (ja) 2019-09-04 2025-08-28 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962895727P 2019-09-04 2019-09-04
US62/895,727 2019-09-04
PCT/US2020/049183 WO2021046207A1 (en) 2019-09-04 2020-09-03 Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025142204A Division JP2025172875A (ja) 2019-09-04 2025-08-28 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用

Publications (4)

Publication Number Publication Date
JP2022546813A JP2022546813A (ja) 2022-11-09
JPWO2021046207A5 true JPWO2021046207A5 (https=) 2023-09-07
JP2022546813A5 JP2022546813A5 (https=) 2023-09-07
JP7818504B2 JP7818504B2 (ja) 2026-02-20

Family

ID=72521748

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022513855A Active JP7818504B2 (ja) 2019-09-04 2020-09-03 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用
JP2025142204A Pending JP2025172875A (ja) 2019-09-04 2025-08-28 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025142204A Pending JP2025172875A (ja) 2019-09-04 2025-08-28 パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用

Country Status (5)

Country Link
US (1) US20220306697A1 (https=)
EP (1) EP4025587A1 (https=)
JP (2) JP7818504B2 (https=)
CN (1) CN114502572A (https=)
WO (1) WO2021046207A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023133435A2 (en) * 2022-01-07 2023-07-13 University Of Washington Novel immunogens for influenza virus vaccines
AU2023273041A1 (en) * 2022-05-17 2024-12-05 Icosavax, Inc. Multivalent vaccine for paramyxoviruses and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2707385T3 (da) 2011-05-13 2017-11-20 Glaxosmithkline Biologicals Sa RSV-F-præfusionsantigener
EA201590683A1 (ru) 2012-11-20 2015-11-30 Глаксосмитклайн Байолоджикалс С.А. Тримеры rsv f, предшествующие слиянию
US20140141037A1 (en) 2012-11-20 2014-05-22 Novartis Ag Rsv f prefusion trimers
US9738689B2 (en) 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use
FI2970398T3 (fi) 2013-03-13 2024-08-06 Us Health Rsv f -prefuusioproteiineja ja niiden käyttö
US9060975B2 (en) 2013-03-14 2015-06-23 Mucosis Bv Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions
JP6469081B2 (ja) 2013-04-25 2019-02-13 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． 安定化された可溶性融合前ｒｓｖｆポリペプチド
MY171210A (en) 2013-06-17 2019-10-02 Janssen Vaccines & Prevention Bv Stabilized soluble pre-fusion rsv f polypeptides
US20150166610A1 (en) 2013-10-14 2015-06-18 Glaxosmithkline Biologicals, S.A. Recombinant rsv antigens
CA2996762A1 (en) 2015-08-31 2017-03-09 Technovax, Inc. Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine
EP3393512B1 (en) 2015-12-23 2025-11-19 Pfizer Inc. Rsv f protein mutants
US11174292B2 (en) 2016-03-29 2021-11-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Substitutions-modified prefusion RSV F proteins and their use
IL264119B2 (en) 2016-05-30 2023-04-01 Janssen Vaccines Prevention B V f proteins of rsv are stabilized before fusion
WO2017207477A1 (en) 2016-05-30 2017-12-07 Janssen Vaccines & Prevention B.V. Stabilized pre-fusion rsv f proteins
US10818377B2 (en) * 2016-11-16 2020-10-27 University Of Washington Computational design of self-assembling cyclic protein homo-oligomers
KR102774312B1 (ko) * 2017-04-04 2025-03-05 유니버시티 오브 워싱톤 파라믹소바이러스 및/또는 뉴모바이러스 f 단백질을 표시하는 자가-조립 단백질 나노구조체 및 이의 용도

Similar Documents

Publication Publication Date Title
JP7541701B2 (ja) パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用
JP2023002680A5 (https=)
JP2020515280A5 (https=)
US11998597B2 (en) Vaccine against RSV
JP2023018073A5 (https=)
JP2025172875A (ja) パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を提示する自己組織化タンパク質ナノ構造体ならびにその使用
JPWO2021046207A5 (https=)
HK40014567A (en) Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
HK40014567B (en) Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
RU2021132097A (ru) Белки rsv f в предшествующей слиянию конформации и их применение